IR Contact
Carlo Tanzi, Ph.D.Seres Therapeutics, Inc.Head of Investor Relations and Corporate Communications Phone: 617-203-3467 E-mail: ctanzi@serestherapeutics.com |
Carlo Tanzi, Ph.D.Seres Therapeutics, Inc.Head of Investor Relations and Corporate Communications Phone: 617-203-3467 E-mail: ctanzi@serestherapeutics.com |